Fisher Financial Statements From 2010 to 2025
| FSPKFDelisted Stock | USD 20.70 0.00 0.00% |
Check Fisher Paykel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fisher Paykel's main balance sheet or income statement drivers, such as , as well as many indicators such as . Fisher financial statements analysis is a perfect complement when working with Fisher Paykel Valuation or Volatility modules.
Fisher |
Fisher Paykel Healthcare Company Profit Margin Analysis
Fisher Paykel's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Fisher Paykel Profit Margin | 0.17 % |
Most of Fisher Paykel's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fisher Paykel Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Fisher Paykel Healthcare has a Profit Margin of 0.1705%. This is 101.52% lower than that of the Healthcare sector and 100.94% lower than that of the Medical Instruments & Supplies industry. The profit margin for all United States stocks is 113.43% lower than that of the firm.
Fisher Paykel Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fisher Paykel's current stock value. Our valuation model uses many indicators to compare Fisher Paykel value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fisher Paykel competition to find correlations between indicators driving Fisher Paykel's intrinsic value. More Info.Fisher Paykel Healthcare is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fisher Paykel Healthcare is roughly 1.64 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fisher Paykel's earnings, one of the primary drivers of an investment's value.About Fisher Paykel Financial Statements
Fisher Paykel stakeholders use historical fundamental indicators, such as Fisher Paykel's revenue or net income, to determine how well the company is positioned to perform in the future. Although Fisher Paykel investors may analyze each financial statement separately, they are all interrelated. For example, changes in Fisher Paykel's assets and liabilities are reflected in the revenues and expenses on Fisher Paykel's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Fisher Paykel Healthcare. Please read more on our technical analysis and fundamental analysis pages.
Fisher Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. Fisher Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand. Fisher Paykel operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6769 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Fisher Pink Sheet
If you are still planning to invest in Fisher Paykel Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fisher Paykel's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |